Posted:
8/4/2025, 5:00:00 PM
Location(s):
Tokyo, Japan
Experience Level(s):
Senior
Field(s):
Operations & Logistics
Summary of purpose/major responsibilities
The Clinical Operations and Study Leader (COSL) combines Clinical project and study oversight roles and responsibilities for Vaccines projects activities.
For projects activities (project and study oversight, CTD submission, PAI…), the COSL will cover both COL and GSM activities.
The COSL is a key leadership role within the assigned project. The COSL directs and manages clinical operational activities to support the Global Clinical Development Strategy Expert (GCDSE) and the clinical team in project and study activities.
She/he is accountable for ensuring study activities and clinical deliverables are on time and within budget, collaborating actively with all functions in the project and clinical teams as well as functions in Clinical.
The COSL is the trusted and reliable chief liaison between the various platforms within GCD and acts as well as an interface with other enabling functions such as JPH, GPM, GRA, PSPV, CMQO, GMA, EPI, BSM, and GI, especially in the context of issues resolution. Therefore, it involves working with multiple levels of personnel from many platforms, in multiple regions, as well as with external stakeholders (e.g., advisory boards, CROs).
The COSL is accountable for ensuring the deliverables of the clinical project and/or studies activities via effective project management and leadership skills in a manner that will optimize integrate and utilize the team’s resources and competencies. The COSL will support the clinical project and studies strategy by providing expertise to develop the best operational strategy for the successful conduct of the project and delivery of the studies. It requires an excellent understanding of franchise/project strategic objectives, clinical operational activities, and clinical studies constraints including Japan regulations, as well as superior interpersonal skills.
The COSL ensures an effective cross functional communication and consolidates strategic communication at project level as well as study level.
The COSL supports innovation and entrepreneurial mindset such as clinical trial designs, digital methodologies, and tools as well as organization within the extended clinical and clinical teams.
The COSL is a key role in risk management initiatives and coordinates crisis management within the project/studies.
The chief accountability is to ensure reliable performance and productivity of Clinical project/studies by leading and coordinating project and studies activities and services. Accountable for both project and study deliverables within GCD, including the timelines, quality and budget.
Key accountabilities
Project strategy and coordination
May be responsible for more than one clinical project, and/or clinical studies depending on project scope and individual experience.
**Coordinates the Clinical Team with the GCDSE for the operational aspects of the study:
- Organizes study specific meetings
- Ensures study operational feasibility is properly done and considered working with other functions and integrates feedback in study plan and risks (GRA timelines, country selection, recruitment potentials, budget needs).
- Ensures study progress is aligned with the projections: coordinates information on clinical timelines from all contributors (including IMP and NIMP by updating the CSC Order Management tool), proactively addresses potential time slippage and coordinates the clinical team’s plans to meet the study timelines.
- Ensures the Clinical Team communication is properly set-up.
- Ensures proper setup of Trial Management tools and adequate management of study documentation availability and tool access
** Collects, synthesizes and reports study information
** Participates in selection and management of vendors and operational experts, development and follow-up of the associated budget when needed
** Is accountable for preparation and follow-up of study budget
** Collaborates to the preparation and oversight of study audits/ pre-approval inspections (PAI)/inspections
Communication/Interfaces
Leadership
Budget
Learning/continuous improvement
Requirements
At least Master degree in relevant scientific and/or medical field and a minimum of 8 years’ experience in clinical research in pharmaceutical industry. Very strong project management experience is required. A proven track record of effectively leading multifunctional teams is needed.
Certifications:
Strong project management skills, transversal and strategic leadership capabilities, communication skills and business acumen are required. Ability to drive a high performing cross functional team that empowers and motivates individual members and the team. Strong interpersonal skills required to effectively collaborate with customers (physicians, scientists and managers from various disciplines) and interfaces to set and manage expectations.
Selling Points:
1. Cross-functional Leadership: COSL coordinates global teams to ensure seamless clinical trial execution and strategic alignment.
2. Project Management Expertise: Ensures clinical trials meet timelines, budgets, and quality standards, aligning with global objectives.
3. Innovation and Improvement: Drives adoption of new trial designs and digital solutions, fostering efficiency and team development.
Better is out there. Better medications, better outcomes, better science. But progress doesn’t happen without people – people from different backgrounds, in different locations, doing different roles, all united by one thing: a desire to make miracles happen. So, let’s be those people.
At Sanofi, we provide equal opportunities to all regardless of race, colour, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, ability or gender identity.
Watch our ALL IN video and check out our Diversity Equity and Inclusion actions at sanofi.com!
Website: https://www.sanofi.com/
Headquarter Location: Paris, Ile-de-France, France
Employee Count: 10001+
Year Founded: 1973
IPO Status: Public
Last Funding Type: Post-IPO Debt
Industries: Health Care ⋅ Life Science ⋅ Pharmaceutical ⋅ Therapeutics